CUR-mediated disruption of AGE–RAGE signaling likely contributes to PI3K/Akt pathway activation and NFκB suppression, thereby alleviating hepatic oxidative stress and inflammation in T2DM. Here, AKT1 is linked to type 2 diabetes mellitus.